OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.910
+0.160 (3.37%)
Dec 20, 2024, 4:00 PM EST - Market closed

OptimizeRx Revenue

OptimizeRx had revenue of $21.31M in the quarter ending September 30, 2024, with 30.48% growth. This brings the company's revenue in the last twelve months to $88.18M, up 40.40% year-over-year. In the year 2023, OptimizeRx had annual revenue of $71.52M with 14.53% growth.

Revenue (ttm)
$88.18M
Revenue Growth
+40.40%
P/S Ratio
1.01
Revenue / Employee
$648,379
Employees
136
Market Cap
90.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202371.52M9.07M14.53%
Dec 31, 202262.45M1.16M1.89%
Dec 31, 202161.29M17.98M41.51%
Dec 31, 202043.31M18.72M76.08%
Dec 31, 201924.60M3.39M15.99%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Bioscience 97.73M
Exagen 55.75M
LENSAR 48.87M
Coya Therapeutics 9.55M
Adagene 815.75K
Monogram Technologies 365.00K
Zentek 29.13K
Revenue Rankings